Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

OBJECTIVES: The objective of this study was to contribute long-term safety data for infliximab and other therapies in Crohn's disease (CD). METHODS: We prospectively evaluated CD patients enrolled in the large, observational Crohn's Therapy, Resource, Evaluation, and Assessment Tool regist...

Descripción completa

Detalles Bibliográficos
Autores principales: Lichtenstein, Gary R, Feagan, Brian G, Cohen, Russell D, Salzberg, Bruce A, Diamond, Robert H, Price, Samiyeh, Langholff, Wayne, Londhe, Anil, Sandborn, William J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438468/
https://www.ncbi.nlm.nih.gov/pubmed/22890223
http://dx.doi.org/10.1038/ajg.2012.218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438468/
https://www.ncbi.nlm.nih.gov/pubmed/22890223
http://dx.doi.org/10.1038/ajg.2012.218

Ejemplares similares